| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99215 |
Prolong outpt/office vis |
4,805 |
4,119 |
$519K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,076 |
882 |
$78K |
| 36410 |
|
1,828 |
1,613 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,241 |
978 |
$9K |
| 81000 |
|
2,907 |
2,471 |
$8K |
| 99205 |
Prolong outpt/office vis |
76 |
58 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
427 |
332 |
$6K |
| 81001 |
|
534 |
486 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
163 |
62 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
73 |
50 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23 |
17 |
$893.68 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
24 |
17 |
$828.59 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
105 |
74 |
$784.00 |
| 82043 |
|
79 |
75 |
$372.00 |
| 36415 |
Collection of venous blood by venipuncture |
217 |
185 |
$332.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
20 |
16 |
$246.30 |
| 82950 |
|
52 |
49 |
$234.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
185 |
131 |
$122.53 |
| 90688 |
|
15 |
12 |
$102.40 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
92 |
71 |
$52.71 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
12 |
$40.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
230 |
170 |
$39.29 |
| 3078F |
|
228 |
167 |
$0.00 |
| 3077F |
|
22 |
13 |
$0.00 |
| 3080F |
|
40 |
25 |
$0.00 |
| 3075F |
|
173 |
127 |
$0.00 |
| 3074F |
|
28 |
17 |
$0.00 |